B

Biotalys NV
BTLS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€126.44M
EV
€112.91M
Shares Outstanding
38.17M
Beta
0.88
Industry
Agricultural Inputs

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
2
P/E 2024E
-
P/Revenue 2024E
44.59x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2024E
-
Net Profit Margin 2024E
-
ROE 2024E
-
ROCE 2023
-64.41%

Dividends

DPS 2024E
-
Payout Ratio 2024E
-
Div. Yield 2024E
-
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Biotalys NV

gainify

B

Biotalys NV

BTLS

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates ...

Sector

Basic Materials

Industry

Agricultural Inputs

CEO

Helash, Kevin

Employees

63

IPO Date

2021-07-02

Headquarters

Buchtenstraat 11, Gent, East Flanders, 9051, Belgium

📊 Stock Price & Performance

The last closing price of Biotalys NV (BTLS) is €3.37, reflecting a +0.30% change from the prior session. Last updated: December 31, 2025 at 6:57 AM Eastern Time

Review the recent BTLS stock performance trends:Past 1 Month: Biotalys NV (BTLS) shares have -26.42%.Past 3 Months: The stock has -25.93%.Past 6 Months: BTLS shares have -29.35%. Last updated: December 31, 2025 at 11:44 PM Eastern Time

Over the last year, Biotalys NV (BTLS) has established a 52-week price range between a high of €5.50 and a low of €2.51. This metric is essential for assessing the stock's annual volatility. Last updated: December 31, 2025 at 11:44 PM Eastern Time

Biotalys NV (BTLS) is considered a medium volatility stock. It has a beta of 0.88, which means it typically moves 0.88 times as much as the broader market. Over the past 52 weeks, BTLS has traded within a €2.51 – €5.50 range. Last updated: December 31, 2025 at 11:44 PM Eastern Time

Based on current BTLS analyst forecasts and market assumptions, the consensus price target for Biotalys NV (BTLS) is €7.30 for 2027. Relative to the current price of €3.37, this implies a positive upside of +116.62%. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated: December 31, 2025 at 11:44 PM Eastern Time

💰 Financial Metrics & Reports

The current Biotalys NV (BTLS) market capitalization is approximately €126.44M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Biotalys NV's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:44 PM Eastern Time

In the most recently reported fiscal year, Biotalys NV (BTLS) generated net income of €-20.51M, compared with €-22.73M in the prior fiscal year, representing a +9.77% year over year change. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions.

📅 Earnings & Dividends

Biotalys NV (BTLS) does not currently pay a dividend. Over the last twelve months (LTM), the company paid €0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.

📈 Analyst Information

Analyst assessments of whether Biotalys NV (BTLS) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: €3.37Consensus price target: €7.30Implied return: +116.62% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: December 31, 2025 at 6:57 AM Eastern Time

Based on the latest available analyst coverage, Biotalys NV (BTLS) currently carries a Buy consensus rating. Analysts' average BTLS price target is €7.30. Relative to the current share price of €3.37, this suggests a potential price change of approximately +116.62%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: December 31, 2025 at 6:57 AM Eastern Time

Like other publicly traded stocks, Biotalys NV (BTLS) shares are bought and sold on stock exchanges such as ENXTBR and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Biotalys NV (BTLS) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add BTLS to your watchlist.

Biotalys NV trades under the ticker symbol BTLS on the ENXTBR stock exchange. The ticker BTLS is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

As of the most recently reported period, Biotalys NV (BTLS) employs approximately 63 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: December 31, 2025 at 11:44 PM Eastern Time

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.